| 1 |
Angel M, Petrosyan Y, Doyle M, Cooper C. HCV infection characteristics, treatment uptake and outcomes in patient with diabetes mellitus. BMC Endocr Disord 2022;22:277. [DOI: 10.1186/s12902-022-01198-x] [Reference Citation Analysis]
|
| 2 |
Farshadpour F, Taherkhani R, Saberi F. Molecular evaluation of hepatitis B virus infection and predominant mutations of pre-core, basal core promoter and S regions in an Iranian population with type 2 diabetes mellitus: a case-control study. BMC Infect Dis 2022;22:553. [PMID: 35715756 DOI: 10.1186/s12879-022-07528-7] [Reference Citation Analysis]
|
| 3 |
Beliy PA, Dudina KR, Znoyko OO, Markova TN, Morozova IA, Blokhina NP, Nurmukhametova EA, Yushchuk ND. Prevalence of chronic HCV infection in patients with type 2 diabetes mellitus in Russia. Diabetes mellitus 2022;25:4-13. [DOI: 10.14341/dm12847] [Reference Citation Analysis]
|
| 4 |
Beykaso G, Mulu A, Giday M, Berhe N, Selamu M, Mihret A, Teklehaymanot T. Burden and Transmission Risks of Viral Hepatitis in Southern Ethiopia: Evidence Needed for Prevention and Control Measures. Risk Manag Healthc Policy 2021;14:4843-52. [PMID: 34880693 DOI: 10.2147/RMHP.S336776] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 5 |
Farshadpour F, Taherkhani R, Bakhtiari F. Prevalence and Predominant Genotype of Hepatitis C Virus Infection and Associated Risk Factors among Pregnant Women in Iran. Biomed Res Int 2021;2021:9294276. [PMID: 34589552 DOI: 10.1155/2021/9294276] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 6 |
Lontchi-Yimagou E, Feutseu C, Kenmoe S, Djomkam Zune AL, Kinyuy Ekali SF, Nguewa JL, Choukem SP, Mbanya JC, Gautier JF, Sobngwi E. Non-autoimmune diabetes mellitus and the risk of virus infections: a systematic review and meta-analysis of case-control and cohort studies. Sci Rep 2021;11:8968. [PMID: 33903699 DOI: 10.1038/s41598-021-88598-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 7 |
Djuric O, Massari M, Ottone M, Collini G, Mancuso P, Vicentini M, Nicolaci A, Zannini A, Zerbini A, Manicardi V, Kondili LA, Giorgi Rossi P. Hepatitis C virus cascade of care in the general population, in people with diabetes, and in substance use disorder patients. Infect Agent Cancer 2021;16:5. [PMID: 33468188 DOI: 10.1186/s13027-021-00345-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Saleh P, Sheikholeslami A, Salman Mohajer A, Babapour S, Hosseini M; Infectious and Tropical Disease Research Center, Department of Infectious and Tropical Disease, Tabriz University of Medical Sciences, Tabriz, Iran, Infectious and Tropical Disease Research Center, Department of Infectious and Tropical Disease, Tabriz University of Medical Sciences, Tabriz, Iran, Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran, Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran, Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran. Association between Different Hepatitis C Virus Genotypes Infection and Type-2 Diabetes Mellitus: A Descriptive-Analytical Study from the Northwest of Iran. JoMMID 2020;8:137-42. [DOI: 10.29252/jommid.8.4.137] [Reference Citation Analysis]
|
| 9 |
Daryabor G, Atashzar MR, Kabelitz D, Meri S, Kalantar K. The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System. Front Immunol 2020;11:1582. [PMID: 32793223 DOI: 10.3389/fimmu.2020.01582] [Cited by in Crossref: 89] [Cited by in F6Publishing: 99] [Article Influence: 29.7] [Reference Citation Analysis]
|
| 10 |
Feng X, Ding T, Liu Y, Xu W, Cheng X. In-silico identification of peroxisome proliferator-activated receptor (PPAR)α/γ agonists from Ligand Expo Components database. Journal of Biomolecular Structure and Dynamics 2021;39:1853-64. [DOI: 10.1080/07391102.2020.1745279] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Merza M. Seroprevalence and risk factors of hepatitis B and C viruses among diabetes mellitus patients in Duhok province, Iraqi Kurdistan. J Family Med Prim Care 2020;9:642. [DOI: 10.4103/jfmpc.jfmpc_1158_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 12 |
Shokri S, Mahmoudvand S, Taherkhani R, Farshadpour F, Jalalian FA. Complexity on modulation of NF-κB pathways by hepatitis B and C: A double-edged sword in hepatocarcinogenesis. J Cell Physiol 2019;234:14734-42. [PMID: 30741410 DOI: 10.1002/jcp.28249] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 13 |
Colaci M, Malatino L, Antonelli A, Fallahi P, Giuggioli D, Ferri C. Endocrine disorders associated with hepatitis C virus chronic infection. Rev Endocr Metab Disord 2018;19:397-403. [PMID: 30499080 DOI: 10.1007/s11154-018-9475-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
